Xinghai Li

Q: What is Xinghai Li email address?

Email Xinghai Li at lixinghai999@gmail.com. This email is the most updated Xinghai Li's email found in 2026.

Q: How to contact Xinghai Li?

To contact Xinghai Li send an email to lixinghai999@gmail.com. If you want to call Xinghai Li try calling on (86) 139 1872 9082.

Chief Scientific Officer, Co-founder, Director at Hinvoa Pharmaceuticals Inc. | Chengdu, Sichuan, China

About Xinghai Li

Xinghai Li, MD/MS/PhD, serves as the Chief Scientific Officer, Co-founder, and Director at Hinova Pharmaceuticals Inc., where he leverages over 20 years of extensive experience in biomedical research and pharmaceutical discovery and development. Under his leadership, Hinova has established a robust drug discovery and clinical development team, focusing on innovative therapies that address significant unmet medical needs. His strategic vision has been instrumental in building a diverse pipeline that includes one therapy currently in an international multi-center Phase III trial, another in Phase I, and two candidates in IND-enabling studies, alongside two additional projects in lead optimization.

Prior to co-founding Hinova, Xinghai held prominent roles in leading pharmaceutical companies, including as a senior scientist at Merck MRL in New Jersey and as a senior director at ChemPartner in Shanghai. His tenure at AstraZeneca Innovation Center as a director and project leader further honed his expertise in drug development, particularly in the realms of immunology, diabetes, and cancer therapeutics. Xinghai's proficiency in molecular pharmacology and biochemistry, combined with his skills in lead optimization and protein characterization, has enabled him to drive drug discovery from pre-clinical stages through to clinical development, with notable success in initiating Phase I trials in China.

Xinghai's commitment to advancing healthcare through innovative solutions is reflected in his hands-on approach to research and development, fostering collaboration among multidisciplinary teams to accelerate the translation of scientific discoveries into viable therapeutic options. His work not only exemplifies leadership in the pharmaceutical industry but also underscores a dedication to improving patient outcomes through novel therapeutic strategies.

Xinghai Li Work